LAMEA PET-CT Scanner Device Market Size, Share & Industry Trends Analysis Report By Slice Count, By Isotope/Detector Type, By Service Provider, By Type, By Application, By Country and Growth Forecast, 2021-2027

The Latin America, Middle East and Africa PET-CT Scanner Device Market is expected to witness market growth of 9.0% CAGR during the forecast period (2021-2027).

Some of the growth catalysts for the overall PET-CT Scanner Device Market are the rise in prevalence of chronic illnesses around the world, rising demand for effective diagnostic systems, and greater Medicare coverage for PET-CT scanning. Currently, there has been the increased use of PET-CT for cancer detection, the introduction of novel products, and company investments in R&D. Moreover, constant developments in healthcare infrastructure in developing countries is expected to offer lucrative growth opportunities for the industry players. However, limited shelf life and insufficient availability of radiopharmaceuticals is expected to pose a major challenge for these market players.

For the appropriate diagnosis of diseases such as cancer, cardiovascular disease, some infectious diseases, and brain problems, both positron emission tomography (PET) and computed tomography (CT) scans are required. In addition, CT scanners highlight anatomical characteristics of the body, whereas PET scanners detect metabolic activity. Moreover, the PET-CT scanner combines the strengths of both scanners, allowing for more precise diagnosis as well as disease localization and surveillance. Further, it also saves space in imaging facilities and gives physicians less time to elevate scans.

The Middle East is a highly dynamic region characterized by a unique blend of civilizations. In addition, the region is changing rapidly in terms of demographics and socioeconomics. Brazil spent 8.3 percent of its $2.5 trillion gross domestic product (GDP) on healthcare in 2014, according to the World Bank. For example, the Aga Khan University Hospital in Nairobi stated in December 2017 that starting in March 2018, it is expected to make PET-CT scanners available for diagnosis. Kenyans formerly had to go to nations like India, South Africa, Egypt, and Morocco, which might incur them a significant treatment cost.

Additionally, the regional market may face some challenges because of its underdeveloped healthcare industry and low healthcare expenditure. On the other hand, the regional fast-increasing healthcare industry and hospital network are creating ideal conditions for arrival and adoption of advanced imaging systems. Hence, these aspects is expected to fuel the growth of the regional PET-CT scanner market during the forecasting period.

The Brazil market dominated the LAMEA PET-CT Scanner Device Market by Country in 2020, and is expected to continue to be a dominant market till 2027; thereby, achieving a market value of $40.6 million by 2027. The Argentina market is estimated to grow at a CAGR of 9.5% during (2021 - 2027). Additionally, The UAE market is expected to expect a CAGR of 8.7% during (2021 - 2027).

Based on Slice Count, the market is segmented into Medium Slice Cardiology (64 Slices), Low Slice Cardiology (< 64 Slices), and High Slice Cardiology (>64 Slices). Based on Isotope/Detector Type, the market is segmented into Flurodeoxyglucose (FDG), 62Cu ATSM, 18 F Sodium Fluoride, FMISO, Gallium, Thallium, and Others. Based on Service Provider, the market is segmented into Hospitals, Diagnostic Centers, and Research Institutes. Based on Type, the market is segmented into Stationary Scanners and Portable Scanners/Mobile Scanners. Based on Application, the market is segmented into Oncology, Cardiology, Neurology, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Bruker Corporation, Toshiba Corporation, Siemens Healthineers AG (Siemens AG), General Electric (GE) Co. (GE Healthcare), Koninklijke Philips N.V., Shimadzu Corporation, Positron Corporation, PerkinElmer, Inc., Mediso Ltd., and Hitachi, Ltd. (Hitachi Healthcare).

Scope of the Study

Market Segments Covered in the Report:

By Slice Count

• Medium Slice Cardiology (64 Slices)
• Low Slice Cardiology (< 64 Slices)
• High Slice Cardiology (>64 Slices)

By Isotope/Detector Type

• Flurodeoxyglucose (FDG)
• 62Cu ATSM
• 18 F Sodium Fluoride
• FMISO
• Gallium
• Thallium
• Others

By Service Provider

• Hospitals
• Diagnostic Centers
• Research Institutes

By Type

• Stationary Scanners
• Portable Scanners/Mobile Scanners

By Application

• Oncology
• Cardiology
• Neurology
• Others

By Country: Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

Key Market Players

List of Companies Profiled in the Report:

• Bruker Corporation
• Toshiba Corporation
• Siemens Healthineers AG (Siemens AG)
• General Electric (GE) Co. (GE Healthcare)
• Koninklijke Philips N.V.
• Shimadzu Corporation
• Positron Corporation
• PerkinElmer, Inc.
• Mediso Ltd.
• Hitachi, Ltd. (Hitachi Healthcare)

Unique Offerings from the Publisher

• Exhaustive coverage
• The highest number of market tables and figures
• Subscription-based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free